Central Serous Chorioretinopathy Associated With a Carcinoma of the Adrenal Cortex

Thoelen, Adelheid M.; Bernasconi, Paolo; Schmid, Christoph; Messmer, Elmar P.

doi:10.1097/00006982-200001000-00020

Cited by 45 publications

(30 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Support for our findings also comes from a recent study that found elevated scores of psychopathological symptoms in CSCR patients when compared with healthy subjects. 6 Increased emotional distress was reported in CSCR, as compared with other eye diseases, such as traumatic ocular injury 13 and ocular histoplasmosis. 14 Associated risk factors for CSCR are male gender, 15 type-A personality, 9 corticosteroid use, 16 and disorders with increased endogenous steroids.…”

Section: Discussionmentioning

confidence: 97%

“…17 Psychological stress is often cited as a precipitating factor in the development of CSCR. 6,9 Garg et al reported that proneness to stress might predispose patients to CSCR. 18 Almost all predisposed factors to CSCR development had a correlation with higher levels of endogenous corticosteroid levels.…”

Section: Discussionmentioning

confidence: 99%

“…2 CSCR is characterized by detachment of the neurosensory retina with accumulation of serous fluid between the retinal pigment epithelium and photoreceptor outer segments. 3 Psychological distress 1,4,5 has been reported among several CSCR risk factors, such as systemic corticosteroid use, 6,7 type-A personality, 8 and pregnancy. 9 In a recent study, Conrad et al have reported higher levels of emotional distress and alexithymia in CSCR patients than those of healthy subjects.…”

Section: Introductionmentioning

confidence: 99%

“…9 In a recent study, Conrad et al have reported higher levels of emotional distress and alexithymia in CSCR patients than those of healthy subjects. 6 However, psychological status of these patients has not thoroughly been studied yet.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Psychological Distress and Poor Quality of Life in Patients with Central Serous Chorioretinopathy

Şahin¹,

Bez

Kaya

et al. 2013

Seminars in Ophthalmology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Psychological Distress and Poor Quality of Life in Patients with Central Serous Chorioretinopathy

Şahin¹,

Bez

Kaya

et al. 2013

Seminars in Ophthalmology

View full text Add to dashboard Cite

show abstract

“…Increased glucocorticosteroid and serum catecholamine levels have been found in patients with CSC [12,44,45,46,47]. However, no increased risk for the development of CSC has been observed after intake of sympathomimetic agents alone [27].…”

Section: Systemic and Ocular Risk Factorsmentioning

confidence: 99%

Central Serous Chorioretinopathy

Liegl¹,

Ulbig²

2014

Ophthalmologica

137

115

View full text Add to dashboard Cite

The pathogenesis of central serous chorioretinopathy (CSC) is still not fully understood. The involvement of corticosteroids is undisputed, although their exact role has not been clarified; other parts of the underlying mechanism of CSC have been mainly elucidated by imaging techniques such as fluorescein and indocyanine green angiography. Even though most cases of CSC are self-limiting, severe as well as recurrent courses exist, and for these patients only a limited number of treatment options are available: laser photocoagulation, with a risk of scotoma and choroidal neovascularization, and photodynamic therapy. In this review article, we give an overview of its epidemiology, the current understanding of its pathogenesis as well as systemic and ocular risk factors. We illuminate modern diagnostic tools as well as current treatment options in the context of CSC, particularly in the light of a better understanding of corticosteroids and their receptors involved in its pathogenesis.

show abstract

Intraocular injections of bevacizumab in rare indications – two cases

et al. 2008

View full text Add to dashboard Cite

Intravitreal anti-VEGF injections are currently the most effective treatment option for neovascular age-related macular degeneration. The anti-VEGF treatment of other, more common ocular diseases, such as diabetic retinopathy and vascular occlusions with neovascularization and retinal edema, is currently described in numerous studies and cases. Rare neovascular ocular diseases, such as Eales disease, presumed ocular histoplasmosis syndrome (POHS), retinopathy of prematurity, and idiopathic telangiectasia, may be future areas for anti-VEGF therapy. In our case report we describe intravitreal bevacizumab (Avastin) therapy for central serous chorioretinopathy and for pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization. In both cases the intravitreal injection resulted in morphological and functional rehabilitation.

show abstract

Central Serous Chorioretinopathy Associated With a Carcinoma of the Adrenal Cortex

Cited by 45 publications

References 0 publications

Psychological Distress and Poor Quality of Life in Patients with Central Serous Chorioretinopathy

Psychological Distress and Poor Quality of Life in Patients with Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Intraocular injections of bevacizumab in rare indications – two cases

Contact Info

Product

Resources

About